Wagner-Rousset E - Search Results

1

NanoLC Chips MS/MS for the characterization of N-glycopeptides generated from trypsin digestion of a monoclonal antibody.

Wagner-Rousset E, Schaeffer-Reiss C, Bednarczyk A, Corvaïa N, Van Dorsselaer A, Beck A. Wagner-Rousset E, et al. Methods Mol Biol. 2013;988:81-91. doi: 10.1007/978-1-62703-327-5_6. Methods Mol Biol. 2013. PMID: 23475715

2

The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies.

Wagner-Rousset E, Bednarczyk A, Bussat MC, Colas O, Corvaïa N, Schaeffer C, Van Dorsselaer A, Beck A. Wagner-Rousset E, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 1;872(1-2):23-37. doi: 10.1016/j.jchromb.2008.03.032. Epub 2008 Apr 15. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18672411

3

Noncovalent mass spectrometry for the characterization of antibody/antigen complexes.

Atmanene C, Wagner-Rousset E, Corvaïa N, Van Dorsselaer A, Beck A, Sanglier-Cianférani S. Atmanene C, et al. Methods Mol Biol. 2013;988:243-68. doi: 10.1007/978-1-62703-327-5_16. Methods Mol Biol. 2013. PMID: 23475725

4

Characterization of the N-terminal heterogeneities of monoclonal antibodies using in-gel charge derivatization of α-amines and LC-MS/MS.

Ayoub D, Bertaccini D, Diemer H, Wagner-Rousset E, Colas O, Cianférani S, Van Dorsselaer A, Beck A, Schaeffer-Reiss C. Ayoub D, et al. Anal Chem. 2015 Apr 7;87(7):3784-90. doi: 10.1021/ac504427k. Epub 2015 Mar 26. Anal Chem. 2015. PMID: 25769014

5

Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins.

Beck A, Wagner-Rousset E, Bussat MC, Lokteff M, Klinguer-Hamour C, Haeuw JF, Goetsch L, Wurch T, Van Dorsselaer A, Corvaïa N. Beck A, et al. Curr Pharm Biotechnol. 2008 Dec;9(6):482-501. doi: 10.2174/138920108786786411. Curr Pharm Biotechnol. 2008. PMID: 19075687 Review.

6

Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS.

Atmanene C, Wagner-Rousset E, Malissard M, Chol B, Robert A, Corvaïa N, Van Dorsselaer A, Beck A, Sanglier-Cianférani S. Atmanene C, et al. Anal Chem. 2009 Aug 1;81(15):6364-73. doi: 10.1021/ac9007557. Anal Chem. 2009. PMID: 19588976

7

[Therapeutic antibodies and related products: choosing the right structure for success].

Beck A, Wagner-Rousset E, Wurch T, Corvaia N. Beck A, et al. Med Sci (Paris). 2009 Dec;25(12):1024-32. doi: 10.1051/medsci/200925121024. Med Sci (Paris). 2009. PMID: 20035674 Free article. Review. French.

8

Characterization of therapeutic antibodies and related products.

Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianférani S. Beck A, et al. Anal Chem. 2013 Jan 15;85(2):715-36. doi: 10.1021/ac3032355. Epub 2012 Dec 14. Anal Chem. 2013. PMID: 23134362 Review. No abstract available.

9

Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.

Marcoux J, Champion T, Colas O, Wagner-Rousset E, Corvaïa N, Van Dorsselaer A, Beck A, Cianférani S. Marcoux J, et al. Protein Sci. 2015 Aug;24(8):1210-23. doi: 10.1002/pro.2666. Epub 2015 Mar 31. Protein Sci. 2015. PMID: 25694334 Free PMC article.

10

Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies.

Beck A, Debaene F, Diemer H, Wagner-Rousset E, Colas O, Van Dorsselaer A, Cianférani S. Beck A, et al. J Mass Spectrom. 2015 Feb;50(2):285-97. doi: 10.1002/jms.3554. J Mass Spectrom. 2015. PMID: 25800010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters